None

Lady Foot Locker Unveils Its "Pink Sass" Collection To Support National Breast Cancer Awareness Month

NEW YORK, Oct. 2, 2012 /PRNewswire/ -- In honor of National Breast Cancer Awareness Month, Lady Foot Locker is proud to present its limited-edition "Pink Sass" collection, available throughout the mon...

Merck Serono and BMS Team Up to Offer Diabetes Drug to China

Merck Serono, a division of Merck KGaA, will collaborate with Bristol-Myers Squibb to promote China distribution of Glucophage®, the type 2 diabetes treatment known generically as metformin. Merck...

Bavarian Nordic to Host First Half 2012 Results Conference Call

KVISTGAARD, Denmark - August 20, 2012 - Bavarian Nordic A/S (OMX:  BAVA) will announce its 2012 first half results on Tuesday, August 28, 2012. The company will host a conference call at 2:00 pm...

Bavarian Nordic to Host Full Year 2012 Conference Call

KVISTGAARD, Denmark - March 6, 2013 - Bavarian Nordic A/S (OMX:  BAVA) will announce its 2012 full year results on Tuesday, March 12, 2013. The company will host a conference call at 2:00 pm CET...

Bavarian Nordic to Host Third Quarter 2012 Results Conference Call

KVISTGAARD, Denmark - November 5, 2012 - Bavarian Nordic A/S (OMX:  BAVA) will announce its interim financial results for the first nine months of 2012 on Tuesday, November 13, 2012. The company wil...

Merck Serono and Bristol-Myers Squibb collaborate on type 2 diabetes treatment for Chinese market

Merck Serono and Bristol-Myers Squibb have established a collaboration for the promotion of type 2 diabetes drug Glucophage (metformin hydrochloride) under different formulations in China through a pr...

Bavarian Nordic to Present at Jefferies 2012 Global Healthcare Conference in London

KVISTGAARD, Denmark, November 8, 2012 - Bavarian Nordic (OMX: BAVA) announced today that Anders Hedegaard, President & CEO will present at the Jefferies 2012 Global Healthcare Conference in Lo...

Bavarian Nordic to Host First Quarter 2013 Results Conference Call

KVISTGAARD, Denmark - May 8, 2013 - Bavarian Nordic A/S (OMX:  BAVA) will announce its 2013 first quarterly results on Thursday, May 16, 2013. The company will host a conference call at 2:00 pm CET...

The Effects of a Cardiac Rehabilitation Program Tailored for Women on Global Quality of Life: A Randomized Clinical Trial.

Abstract Background: Women with heart disease have adverse psychosocial profiles and poor attendance in cardiac rehabilitation (CR) programs. Few studies examine CR programs tailored for women for imp...

Relationships between stress, social adaptation, personality traits, brain-derived neurotrophic factor and 3-methoxy-4-hydroxyphenylglycol plasma concentrations in employees at a publishing company in Japan.

There is growing evidence that blood levels of brain-derived neurotrophic factor (BDNF) and 3-methoxy-4-hydroxyphenylglycol (MHPG), a major metabolite of noradrenaline, are related to depression-assoc...

Genome Sequence of Staphylococcus aureus VC40, a Vancomycin- and Daptomycin-Resistant Strain, To Study the Genetics of Development of Resistance to Currently Applied Last-Resort Antibiotics.

The increasing emergence of multidrug-resistant Staphylococcus aureus is a problem of global importance. Here, we report the genome of S. aureus VC40, which is resistant to the last-resort antibiotics...

Impact of diabetes mellitus on treatment outcomes of tuberculosis patients in tertiary care setup.

: Concurrent diabetes mellitus (DM) with tuberculosis (TB) has an increased risk of treatment failure. This study was aimed to evaluate treatment outcomes in patients with TB with and without DM.

Assessment of depressive symptoms and functional outcomes in patients with major depressive disorder treated with duloxetine versus placebo: primary outcomes from two trials conducted under the same protocol.

OBJECTIVE: Return of functional ability is a central goal in the treatment of major depressive disorder. We conducted two trials with the same protocol that was designed to assess functioning after 8...